0% found this document useful (0 votes)
25 views37 pages

Slide Session

Fabry's disease is an X-linked lysosomal storage disorder characterized by a deficiency of alpha-galactosidase A, leading to the accumulation of glycosphingolipids in various tissues. It presents with cutaneous findings such as angiokeratomas and non-cutaneous manifestations including renal failure and cardiovascular issues. Treatment focuses on symptomatic relief and management of complications, with a prognosis indicating a reduced life expectancy in affected individuals.

Uploaded by

jaleel ahmed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
25 views37 pages

Slide Session

Fabry's disease is an X-linked lysosomal storage disorder characterized by a deficiency of alpha-galactosidase A, leading to the accumulation of glycosphingolipids in various tissues. It presents with cutaneous findings such as angiokeratomas and non-cutaneous manifestations including renal failure and cardiovascular issues. Treatment focuses on symptomatic relief and management of complications, with a prognosis indicating a reduced life expectancy in affected individuals.

Uploaded by

jaleel ahmed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

SLIDE SESSION

Dr Maria
Fabry’s disease

• X-linked lysosomal storage disorder.


• Highly penetrant in males; female heterozygotes have variable
expressivity.
• Partial or complete deficiency of alpha-galactosidase A with
deposition of glycosphingolipids (mostly globotriaosylceramide).
• Neutral sphingolipids with terminal -galactosyl residues
(predominantly globotriaosylceramide [Gb3]) accumulate in the
lysosomes of different tissues and fluids (epithelial cells of
glomeruli and tubules of the kidneys; cardiac myocytes; ganglion
cells of the autonomic system; cornea; endothelial, perithelial, and
smooth muscle cells of blood vessels; and histiocytic and reticular
cells of connective tissue
Cutaneous findings
• Angiokeratomas
• Angiomas
• Telangiectasias
• Lymphedema
• Hypohidrosis/ hyperhidrosis
• Raynaud’s phenomenon
• Pseudoacromegalic facies
Non cutaneous Findings
• Ocular
• Cornea verticillata
• Renal
• Chronic renal failure • Conjunctival vessel aneurysms

• Cardiovascular • Increased tortuosity of retinal vessels

• Hypertension • Fabry cataract


• Coronary vascular disease • GI
• Left ventricle hypertrophy • Diarrhea
• Valve disease • Nausea
• Arrhythmias • Vomiting
• Elevated high-density lipoprotein • Postprandial ank pain
• Neurologic/psychiatric • Malabsorption
• Acroparesthesias • Others
• Cerebrovascular disease • Hearing loss and tinnitus
• Dementia • Hypothyroidism
• Depression • Obstructive airway disease
• Increased suicide ideation • Osteopenia and osteoporosis
HISTOPATHOLOGY
• Dilated, ectatic capillaries in the papillary dermis,
a variably thinned epidermiscentrally, with
epidermal acanthosis at the edges of the lesion,
and variable degrees of overlying focal compact
orthohyperkeratosis
• Endothelial, perithelial, perineural, eccrine,
smooth muscle cells, and fibroblasts are filled
with cytoplasmic vacuoles containing
glycosphingolipid that can be visualized with
toluidine blue stains.
• Electron-dense, lamellated, intracytoplasmic
vacuolar inclusions (Zebra bodies) are typically
seen on electron microscopy
Differential Diagnosis of
Angiokeratomas
ANGIOKERATOMA
LOCALIZED FORMS CORPORIS DIFFUSUM
• Angiokeratoma of Fordyce • Fucosidosis
• Angiokeratoma of the vulva • Aspartylglycosaminuria
• Angiokeratoma of Mibelli • Galactosialidosis
• Solitary papular • Schindler/Kanzaki disease
angiokeratoma • Beta Mannosidosis
• Angiokeratoma • GM-galactosidase
circumscriptum - • Sialidosis
• Idiopathic
Differential diagnosis
• Chloroquine therapy
• Tuberous sclerosis, juvenile dermatomyositis,
also associated with widespread
angiokeratomas
Prognosis
• Life expectancy shortened by 20 years in
males and 15 years in females
TREATMENT
• Symptomatic • Hyperhidrosis
• Angiokeratomas • Aluminium chloride hexahydrate
• Liquid nitrogen • Electrophoresis
• Electrocoagulation • Botulinum toxin
• Surgical excision • Glycopyrrolate sodium
• Laser (pulsed-dye 585 nm, • Raynaud phenomenon
neodynium YAG [Nd:YAG] 1064 nm, • Avoid smoking, cold and
• combined pulsed-dye and Nd:YAG) vasoconstrictor therapies
and intense pulsed light • Losartan
• Lymphedema • Diltiazem
• Manual lymphatic drainage massage • Fluoxetine
and compression • Sildenal
Treatment
• Pain • Cardiovascular
• Avoid triggers • Antihypertensive drugs
• Diphenylhydantoin • Antiarrhythmia drugs
• Carbamazepine • Articial pacemakers
• Gabapentin • Implantable debrillators
• Stroke • Coronary bypass
• Chronic renal failure
• Antiplatelet
• Angiotensin converting enzyme
• Anticoagulant inhibitors
• Hearing • Hemodialysis
• Hearing aid devices • Allograft transplant
• Avoid noise trauma • -Galactosidase B (Fabrazyme)
• Lungs • -Galactosidase A (Replagal)
• Avoid smoking • Migalastat (for patients with amenable
mutations
• Bronchodilators
• GI
• Pancrelipase
• Metoclopramide
DIFFERENTIAL DIAGNOSIS
• GRANULOMA ANNULARE
• Tinea corporis

• Subacute cutaneous lupus erythematosus

• Annular lichen planus

• Actinic granuloma/annular elastolytic giant cell


granuloma
Granuloma annulare

• It is a disease of the skin and subcutaneous tissue


characterized by granulomatous annular plaques, nodules or
papules containing foci of altered collagen surrounded by
histiocytes and lymphocytes
GRANULOMA ANNULARE

• Granuloma annulare is most common in children and young


adults but can occur at any age
• It is twice as common in women as in men
ASSOCIATIONS

• The prevalence of diabetes is probably not increased amongst


patients with GA
• Autoimmune thyroiditis, uveitis, hyperlipidaemia, temporal
arteritis, morphoea, necrobiosis lipoidica and sarcoidosis
have also been reported
• HLA‐Bw35
VARIANTS OF GA

• Localized
• Generalized,
• Subcutaneous
• Perforating.
GA represents a reaction pattern to a variety of triggering factors
• Infections and infestations • Sunlight exposure
• Scabies , • Drug‐induced GA
• hepatitis B , • tumour necrosis factor α (TNF‐α)
• Mycobacterium tuberculosis , blockers
• human papillomavirus , • Erythema multiforme
• varicella/zoster , Epstein–Barr virus
, parvovirus B19 , hepatitis C , HIV
and
• Borrelia burgdorferi
• Traumatic triggers
• immunizations , tuberculin testing
• animal and insect bites ,
• waxing and saphenectomy
• Perforating GA has also been
reported in the red areas of tattoos
Pathology

• The most characteristic histological lesion in GA is the


necrobiotic granuloma, but there are three histological
patterns that mayoccur:
• (i) necrobiotic palisading granulomas;
• (ii) interstitial form; and
• (iii) granulomas of sarcoidal or tuberculoid type
Complications and co‐morbidities

• Anetoderma
• Mid‐dermal elastolysis
Disease course and prognosis

• 50% of patients the lesions resolve within 2


years. However, about 40% recurrence occurs
in the majority of cases at the same sites
Treatment ladder
First line
• No treatment/expectant
• Cryotherapy
• Intralesional corticosteroid
• Potent topical corticosteroid
Second line
• Topical tacrolimus
• Pimecrolimus
• Imiquimod
• Narrow‐band UVB phototherapy
• PUVA
• Dapsone
• Ciclosporin
• Fumaric acid esters
• Methotrexate
Third line
• Photodynamic therapy
• Laser
Multiple large crateriform nodules with central keratinous contents
on the back of a patient with hypothyroidism
Differential Diagnosis

• Acquired perforating disorder


• Actinic granuloma (annular elastolytic giant cell granuloma

• Lichen planus
• Multiple keratoacanthomas (Ferguson-Smith familial
keratoacanthomas,
• Perforating granuloma annulare
• Perforating periumbilical calcic elastosis
• Perforating pseudoxanthoma elasticum
• Porokeratosis
• Prurigo nodularis
• Psoriasis
• Sarcoidosis
• Scabies
Acquired perforating disorders
• Acquired perforating disorders represent a
group of separately identifed cutaneous
disorders that occur most often in the setting
of chronic renal disease or diabetes mellitus.
Acquired perforating disorders
• KYRLE DISEASE/
• ACQUIRED PERFORATING COLLAGENOSIS
• PERFORATING FOLLICULITIS
• ACQUIRED ELASTOSIS PERFORANS
SERPIGINOSA
Conditions Associated with Acquired
Perforating Dermatosis
• Common Associations
• Chronic kidney disease
• Diabetes mellitus (insulin-dependent and noninsulin-dependent)
• Scabies
• Rare Associations
• AIDS
• Arthropod bites
• Atopic dermatitis
• Cutaneous cytomegalovirus infection
• Hyperparathyroidism
• Liver diseases
• Lupus vulgaris
• Myelodysplastic syndrome
• Malignancy
• Mikulicz disease
• Neurodermatitis
• Poland syndrome
• Primary sclerosing cholangitis
• Pulmonary aspergillosis
• Pulmonary brosis
• Salt water application
• Thyroid disease
• Vitamin A deciency
HISTOPATHOLOGY
• Histopathologic examination of lesional skin
demonstrates invagination of the epidermis
with extrusion of dermal material (collagen,
elastin, and/or fibrin) through the cup-shaped
epidermal depression.
PROGNOSIS
• APD may improve with successful treatment
of the underlying illness. Most cases of APD
continue for years unless treated.
• Topical Therapies
• Retinoic acid
• Tretinoin
• Tazarotene
• Beclomethasone Corticosteroid
• Triamcinolone acetonide
• Corticosteroid 10 mg/mL intralesional injection
• Imiquimod
• Phenol
• Capsaicin
• Systemic Therapies
• Isotretinoin
• Acitretin
• Prednisolone
• Allopurinol
• Doxycycline
• Metronidazole
• Clindamycin
• Hydroxychloroquine
• Physical modalities
• UVB
• NUVB
• PUVA
• Liquid nitrogen
• CO2 LASER
• Surgical debridement
THANKS

You might also like